12/05/2004

Cholesterol drug to be sold over-the-counter

A drug that can reduce the risk of heart attacks is to become available without a prescription for the first time, Health Secretary John Reid announced today.

The Committee on Safety of Medicines (CSM) has advised the government that the cholesterol-lowering statin, simvastatin, should be available without prescription in a 10mg dose.

Statins are designed to reduce heart attacks by lowering cholesterol levels - heart attacks can be cut one-third in users after three years of taking the drug, the health department said.

Currently, statins are prescribed to 1.8 million people and are believed to save between 6,000 and 7,000 lives a year. Coronary heart disease is the country's single biggest killer and more than 110,000 people in England die from the disease every year.

Accepting the committee's recommendation, Mr Reid said: "This new move will allow more people to protect themselves from the risk of coronary heart disease and heart attacks.

"By extending access to this drug we are giving people more choice about how they protect their health. We are committed to extending choice whenever advised it is safe to do so."

Simvastatin, which has been available in the UK for the last 14 years, has been used by millions of people worldwide and has a very well established safety record, the health department said.

The move will also give pharmacists a "greater role in helping people to stay healthy", according to Dr Reid.

The 10mg dosage of the drug will be available to buy at pharmacies in monthly packs from this summer.

Pharmacists will ask people a series of questions and, where appropriate, offer a range of health tests to ensure that it is safe to issue the drug. Under the plans, statins will still be available on prescription.

Present guidelines suggest that statins should be prescribed for patients who have a 30% chance of heart attack within the next 10 years.

(gmcg)

Related UK National News Stories
Click here for the latest headlines.

09 April 2015
Shorter People More At Risk Of Heart Disease
Shorter people are more at risk of coronary heart disease, according to a new study led by Professor Sir Nilesh Samani, British Heart Foundation Professor of Cardiology and Head of the Department of Cardiovascular Sciences. The research discovered that every 2.5 inches of change in height affects the risk of coronary heart disease by 13.5%.
29 May 2009
Widespread Use Of Aspirin Slammed
A new study in The Lancet medical journal has found that healthy people who take aspirin reduced their already small risk of heart attack or stroke by just 12%. However, the small risk of internal bleeding increased by a third.
02 April 2012
Heart Failure's Effects Can Be Reversed With Rest
Structural changes in heart muscle cells after heart failure can be reversed by allowing the heart to rest, according to research at Imperial College London. Findings from a study in rats published today in the European Journal of Heart Failure show that the condition's effects on heart muscle cells are not permanent, as has generally been thought.
17 October 2008
Aspirin 'Doesn't Prevent Heart Attacks'
Despite GPs prescribing the drugs to many thousands of their patients by way of prevention, new research suggests that aspirin does not after all prevent heart attacks.
20 April 2010
97% Unaware Of 'Muffin Top' Health Risks
Most people have no idea that rolls of fat around their waistline are putting them at increased risk of heart disease, diabetes and cancer, a poll reveals. While being overweight or obese in general poses a health hazard, concentrated fat ­deposits around the midriff – commonly nicknamed spare tyres or muffin tops – are particularly dangerous.